MORELLE MEDICALE
0878.055.876 · rovalta.com · 25/09/2026
MORELLE MEDICALE
Company — Normal situation.
Financial year 2025 · Closed on 30/06/2025
Overview
Identity
Source · BCE/KBOMORELLE MEDICALE is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0878.055.876
- Legal form
- Private company with limited liability
- Contributed capital
- 12 400,00 €
- Latest accounts
- 30/06/2025
Joint committees (2)
- 30502
- 330
Financials
Source · NBB, 20 filingsTrend over 20 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 65,9 k € | -61.9% | 173 k € | -24.3% | 228,6 k € | +7.2% | 213,3 k € | -21.9% | 273,3 k € |
| EBITDA | 64,2 k € | -62.6% | 171,8 k € | -24.4% | 227,2 k € | +7.3% | 211,8 k € | -21.7% | 270,6 k € |
| Operating result | 64,2 k € | -57.4% | 150,6 k € | -24.1% | 198,4 k € | +6.5% | 186,2 k € | -27.6% | 257,2 k € |
| Net result | 69 k € | -39.6% | 114,1 k € | -23.0% | 148,2 k € | +18.0% | 125,7 k € | -27.5% | 173,3 k € |
| Balance sheet | |||||||||
| Equity | 1,4 M € | +5.3% | 1,3 M € | +9.6% | 1,2 M € | +6.6% | 1,1 M € | +12.7% | 992,3 k € |
| Total assets | 1,4 M € | +6.4% | 1,3 M € | +8.6% | 1,2 M € | +8.0% | 1,1 M € | +12.4% | 998,6 k € |
| Cash | 393,9 k € | +390% | 80,5 k € | -28.4% | 112,3 k € | -9.7% | 124,3 k € | -87.1% | 963,8 k € |
| Debts | 22,9 k € | +109% | 10,9 k € | -46.4% | 20,4 k € | +410% | 4 k € | -36.5% | 6,3 k € |
| Other | |||||||||
| Workforce | – | – | – | – | – | ||||
Board of directors
Source · NBB, accounts to 30/06/20251 active · 2 ended
Active mandates
Ended mandates
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 30/06/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 6 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 08/11/2025 | 15/07/2025 | 03/07/2024 | 06/07/2023 | 01/07/2022 | 09/08/2021 |
| General meeting | – | 30/04/2025 | 21/06/2024 | 16/06/2023 | 17/06/2022 | 18/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 20 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 30/06/2025 | — | 08/11/2025 | French | |
| Micro model | 31/12/2024 | 30/04/2025 | 15/07/2025 | French | |
| Micro model | 31/12/2023 | 21/06/2024 | 03/07/2024 | French | |
| Micro model | 31/12/2022 | 16/06/2023 | 06/07/2023 | French | |
| Micro model | 31/12/2021 | 17/06/2022 | 01/07/2022 | French | |
| Micro model | 31/12/2020 | 18/06/2021 | 09/08/2021 | French | |
| Micro model | 31/12/2019 | 19/06/2020 | 03/08/2020 | French | |
| Abridged model | 31/12/2018 | 21/06/2019 | 19/08/2019 | French | |
| Abridged model | 31/12/2017 | 15/06/2018 | 12/07/2018 | French | |
| Abridged model | 31/12/2016 | 16/06/2017 | 18/08/2017 | French | |
| Abridged model | 31/12/2015 | 17/06/2016 | 18/08/2016 | French | |
| Abridged model | 31/12/2014 | 19/06/2015 | 30/06/2015 | French | |
| Abridged model | 31/12/2013 | 20/06/2014 | 21/07/2014 | French | |
| Abridged model | 31/12/2012 | 21/06/2013 | 27/07/2013 | French | |
| Abridged model | 31/12/2011 | 15/06/2012 | 28/06/2012 | French | |
| Abridged model | 31/12/2010 | 17/06/2011 | 05/07/2011 | French | |
| Abridged model | 31/12/2009 | 18/06/2010 | 02/07/2010 | French | |
| Abridged model | 31/12/2008 | 19/06/2009 | 30/06/2009 | French | |
| Abridged model | 31/12/2007 | 20/06/2008 | 21/06/2008 | French | |
| Abridged model | 31/12/2006 | 15/06/2007 | 20/06/2007 | French |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/06/20251 active · 2 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202569 k €↓
- 2024Annual accounts 2024114,1 k €↓
- 2023Annual accounts 2023148,2 k €↑
- 2022Annual accounts 2022125,7 k €↓
- 2021Annual accounts 2021173,3 k €↑
- 2020Annual accounts 2020118,8 k €↓
- 2019Annual accounts 2019120,5 k €↓
- 2018Annual accounts 2018129,6 k €↑
- 2017Annual accounts 2017125,5 k €↑
- 2016Annual accounts 201699,8 k €↑
- 2015Annual accounts 201584,1 k €↑
- 2014Annual accounts 201448,1 k €↓
- 2013Annual accounts 201386,2 k €↑
- 2012Annual accounts 201274,2 k €↑
- 2011Annual accounts 201171,8 k €↓
- 2010Annual accounts 201079,7 k €↓
- 2009Annual accounts 200990,1 k €↑
- 2008Annual accounts 200867,8 k €↑
- 2007Annual accounts 200746,5 k €↓
- 2006Annual accounts 200682,7 k €